Anti Fungal Drugs Market Size, Share & Industry Analysis, By Drug Type (Echinocandins, Azoles, Polyenes, and Allylamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis, and Others), By Route of Administration (Oral, Topical, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Drug Stores, and Others), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI101188

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
2. Prevalence of Fungal Infections
3. Pipeline Analysis
4. New Product Launches
Global Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Drug Type
  1. Azoles
  2. Echinocandins
  3. Polyenes
  4. Allylamines
3. Market Analysis, Insights and Forecast – By Indication
  1. Dermatophytosis
  2. Candidiasis
  3. Aspergillosis
  4. Others
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia pacific
  4. Latin America
  5. Middle East & Africa
North America Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Type
  1. Azoles
  2. Echinocandins
  3. Polyenes
  4. Allylamines
3. Market Analysis – By Indication
  1. Dermatophytosis
  2. Candidiasis
  3. Aspergillosis
  4. Others
4. Market Analysis – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
5. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
6. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Type
  1. Azoles
  2. Echinocandins
  3. Polyenes
  4. Allylamines
3. Market Analysis – By Indication
  1. Dermatophytosis
  2. Candidiasis
  3. Aspergillosis
  4. Others
4. Market Analysis – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
5. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
6. Market Analysis – By Country/ sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia pacific Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Type
  1. Azoles
  2. Echinocandins
  3. Polyenes
  4. Allylamines
3. Market Analysis – By Indication
  1. Dermatophytosis
  2. Candidiasis
  3. Aspergillosis
  4. Others
4. Market Analysis – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
5. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
6. Market Analysis – By Country/ sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Type
  1. Azoles
  2. Echinocandins
  3. Polyenes
  4. Allylamines
3. Market Analysis – By Indication
  1. Dermatophytosis
  2. Candidiasis
  3. Aspergillosis
  4. Others
4. Market Analysis – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
5. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
6. Market Analysis – By Country/ sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Type
  1. Azoles
  2. Echinocandins
  3. Polyenes
  4. Allylamines
3. Market Analysis – By Indication
  1. Dermatophytosis
  2. Candidiasis
  3. Aspergillosis
  4. Others
4. Market Analysis – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
5. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
6. Market Analysis – By Country/ sub-region
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2025)
3. Competition Dashboard
4. Comparative Analysis – Major Players
5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. Astellas Pharma Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  2. Merck & Co., Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  3. Pfizer Inc
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  4. Leadiant Biosciences, Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  5. McKesson Medical-Surgical Inc
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  6. GlaxoSmithKline plc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  7. Novartis AG
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  8. Bayer AG
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  9. Abbott
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  10. Other Prominent Players
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
Strategic Recommendations

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
2. Prevalence of Fungal Infections
3. Pipeline Analysis
4. New Product Launches
Global Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Drug Type
  1. Azoles
  2. Echinocandins
  3. Polyenes
  4. Allylamines
3. Market Analysis, Insights and Forecast – By Indication
  1. Dermatophytosis
  2. Candidiasis
  3. Aspergillosis
  4. Others
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia pacific
  4. Latin America
  5. Middle East & Africa
North America Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Type
  1. Azoles
  2. Echinocandins
  3. Polyenes
  4. Allylamines
3. Market Analysis – By Indication
  1. Dermatophytosis
  2. Candidiasis
  3. Aspergillosis
  4. Others
4. Market Analysis – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
5. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
6. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Type
  1. Azoles
  2. Echinocandins
  3. Polyenes
  4. Allylamines
3. Market Analysis – By Indication
  1. Dermatophytosis
  2. Candidiasis
  3. Aspergillosis
  4. Others
4. Market Analysis – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
5. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
6. Market Analysis – By Country/ sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia pacific Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Type
  1. Azoles
  2. Echinocandins
  3. Polyenes
  4. Allylamines
3. Market Analysis – By Indication
  1. Dermatophytosis
  2. Candidiasis
  3. Aspergillosis
  4. Others
4. Market Analysis – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
5. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
6. Market Analysis – By Country/ sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Type
  1. Azoles
  2. Echinocandins
  3. Polyenes
  4. Allylamines
3. Market Analysis – By Indication
  1. Dermatophytosis
  2. Candidiasis
  3. Aspergillosis
  4. Others
4. Market Analysis – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
5. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
6. Market Analysis – By Country/ sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Anti-Fungal Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Key Findings / Summary
2. Market Analysis – By Drug Type
  1. Azoles
  2. Echinocandins
  3. Polyenes
  4. Allylamines
3. Market Analysis – By Indication
  1. Dermatophytosis
  2. Candidiasis
  3. Aspergillosis
  4. Others
4. Market Analysis – By Route of Administration
  1. Oral
  2. Topical
  3. Parenteral
5. Market Analysis – By Distribution Channel
  1. Hospitals Pharmacies
  2. Retail Pharmacies & Drug Stores
  3. Online Pharmacies
6. Market Analysis – By Country/ sub-region
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2025)
3. Competition Dashboard
4. Comparative Analysis – Major Players
5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. Astellas Pharma Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  2. Merck & Co., Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  3. Pfizer Inc
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  4. Leadiant Biosciences, Inc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  5. McKesson Medical-Surgical Inc
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  6. GlaxoSmithKline plc.
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  7. Novartis AG
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  8. Bayer AG
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  9. Abbott
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
  10. Other Prominent Players
    1. Overview,
    2. Products & services,
    3. SWOT analysis,
    4. Recent developments,
    5. strategies,
    6. financials (based on availability)
Strategic Recommendations

Read Less

List of Figures

Figure 1: Global Anti-Fungal Drugs Market Revenue Breakdown (US$ Bn, %) by Region, 2025 & 2034

Figure 2: Global Anti-Fungal Drugs Market Value Share (%), by Drug Type, 2025 & 2034

Figure 3: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Azoles, 2021-2034

Figure 4: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Echinocandins, 2021-2034

Figure 5: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Polyenes, 2021-2034

Figure 6: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Allylamines, 2021-2034

Figure 7: Global Anti-Fungal Drugs Market Value Share (%), by Indication, 2025 & 2034

Figure 8: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Dermatophytosis, 2021-2034

Figure 9: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Candidiasis, 2021-2034

Figure 10: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Aspergillosis, 2021-2034

Figure 11: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Others, 2021-2034

Figure 12: Global Anti-Fungal Drugs Market Value Share (%), by Route of Administration, 2025 & 2034

Figure 13: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Oral, 2021-2034

Figure 14: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Topical, 2021-2034

Figure 15: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Parenteral, 2021-2034

Figure 16: Global Anti-Fungal Drugs Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 17: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Hospitals Pharmacies, 2021-2034

Figure 18: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Retail Pharmacies & Drug Stores, 2021-2034

Figure 19: Global Anti-Fungal Drugs Market Forecast (US$ Bn), by Online Pharmacies, 2021-2034

Figure 20: Global Anti-Fungal Drugs Market Value (US$ Bn), by Region, 2025 & 2034

Figure 21: North America Anti-Fungal Drugs Market Value (US$ Bn), by Drug Type, 2025 & 2034

Figure 22: North America Anti-Fungal Drugs Market Value Share (%), by Drug Type, 2025

Figure 23: North America Anti-Fungal Drugs Market Value (US$ Bn), by Indication, 2025 & 2034

Figure 24: North America Anti-Fungal Drugs Market Value Share (%), by Indication, 2025

Figure 25: North America Anti-Fungal Drugs Market Value (US$ Bn), by Route of Administration, 2025 & 2034

Figure 26: North America Anti-Fungal Drugs Market Value Share (%), by Route of Administration, 2025

Figure 27: North America Anti-Fungal Drugs Market Value (US$ Bn), by Distribution Channel, 2025 & 2034

Figure 28: North America Anti-Fungal Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 29: North America Anti-Fungal Drugs Market Value (US$ Bn), By Country, 2025 & 2034

Figure 30: North America Anti-Fungal Drugs Market Value Share (%), By Country, 2025

Figure 31: Europe Anti-Fungal Drugs Market Value (US$ Bn), by Drug Type, 2025 & 2034

Figure 32: Europe Anti-Fungal Drugs Market Value Share (%), by Drug Type, 2025

Figure 33: Europe Anti-Fungal Drugs Market Value (US$ Bn), by Indication, 2025 & 2034

Figure 34: Europe Anti-Fungal Drugs Market Value Share (%), by Indication, 2025

Figure 35: Europe Anti-Fungal Drugs Market Value (US$ Bn), by Route of Administration, 2025 & 2034

Figure 36: Europe Anti-Fungal Drugs Market Value Share (%), by Route of Administration, 2025

Figure 37: Europe Anti-Fungal Drugs Market Value (US$ Bn), by Distribution Channel, 2025 & 2034

Figure 38: Europe Anti-Fungal Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 39: Europe Anti-Fungal Drugs Market Value (US$ Bn), By Country/ Sub-region, 2025 & 2034

Figure 40: Europe Anti-Fungal Drugs Market Value Share (%), By Country/ Sub-region, 2025

Figure 41: Asia Pacific Anti-Fungal Drugs Market Value (US$ Bn), by Drug Type, 2025 & 2034

Figure 42: Asia Pacific Anti-Fungal Drugs Market Value Share (%), by Drug Type, 2025

Figure 43: Asia Pacific Anti-Fungal Drugs Market Value (US$ Bn), by Indication, 2025 & 2034

Figure 44: Asia Pacific Anti-Fungal Drugs Market Value Share (%), by Indication, 2025

Figure 45: Asia Pacific Anti-Fungal Drugs Market Value (US$ Bn), by Route of Administration, 2025 & 2034

Figure 46: Asia Pacific Anti-Fungal Drugs Market Value Share (%), by Route of Administration, 2025

Figure 47: Asia Pacific Anti-Fungal Drugs Market Value (US$ Bn), by Distribution Channel, 2025 & 2034

Figure 48: Asia Pacific Anti-Fungal Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 49: Asia Pacific Anti-Fungal Drugs Market Value (US$ Bn), By Country/ Sub-region, 2025 & 2034

Figure 50: Asia Pacific Anti-Fungal Drugs Market Value Share (%), By Country/ Sub-region, 2025

Figure 51: Latin America Anti-Fungal Drugs Market Value (US$ Bn), by Drug Type, 2025 & 2034

Figure 52: Latin America Anti-Fungal Drugs Market Value Share (%), by Drug Type, 2025

Figure 53: Latin America Anti-Fungal Drugs Market Value (US$ Bn), by Indication, 2025 & 2034

Figure 54: Latin America Anti-Fungal Drugs Market Value Share (%), by Indication, 2025

Figure 55: Latin America Anti-Fungal Drugs Market Value (US$ Bn), by Route of Administration, 2025 & 2034

Figure 56: Latin America Anti-Fungal Drugs Market Value Share (%), by Route of Administration, 2025

Figure 57: Latin America Anti-Fungal Drugs Market Value (US$ Bn), by Distribution Channel, 2025 & 2034

Figure 58: Latin America Anti-Fungal Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 59: Latin America Anti-Fungal Drugs Market Value (US$ Bn), By Country/ Sub-region, 2025 & 2034

Figure 60: Latin America Anti-Fungal Drugs Market Value Share (%), By Country/ Sub-region, 2025

Figure 61: Middle East & Africa Anti-Fungal Drugs Market Value (US$ Bn), by Drug Type, 2025 & 2034

Figure 62: Middle East & Africa Anti-Fungal Drugs Market Value Share (%), by Drug Type, 2025

Figure 63: Middle East & Africa Anti-Fungal Drugs Market Value (US$ Bn), by Indication, 2025 & 2034

Figure 64: Middle East & Africa Anti-Fungal Drugs Market Value Share (%), by Indication, 2025

Figure 65: Middle East & Africa Anti-Fungal Drugs Market Value (US$ Bn), by Route of Administration, 2025 & 2034

Figure 66: Middle East & Africa Anti-Fungal Drugs Market Value Share (%), by Route of Administration, 2025

Figure 67: Middle East & Africa Anti-Fungal Drugs Market Value (US$ Bn), by Distribution Channel, 2025 & 2034

Figure 68: Middle East & Africa Anti-Fungal Drugs Market Value Share (%), by Distribution Channel, 2025

Figure 69: Middle East & Africa Anti-Fungal Drugs Market Value (US$ Bn), By Country/ Sub-region, 2025 & 2034

Figure 70: Middle East & Africa Anti-Fungal Drugs Market Value Share (%), By Country/ Sub-region, 2025

Figure 71: Global Anti-Fungal Drugs Market Share (%), By Company, 2025

List of Tables

Table 1: Global Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2021–2034

Table 2: Global Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2021–2034

Table 3: Global Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2021–2034

Table 4: Global Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2021–2034

Table 5: Global Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Region, 2021-2034

Table 6: North America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2021-2034

Table 7: North America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2021-2034

Table 8: North America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2021-2034

Table 9: North America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2021-2034

Table 10: North America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, By Country, 2021-2034

Table 11: Europe Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2021-2034

Table 12: Europe Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2021-2034

Table 13: Europe Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2021-2034

Table 14: Europe Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2021-2034

Table 15: Europe Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034

Table 16: Asia Pacific Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2021-2034

Table 17: Asia Pacific Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2021-2034

Table 18: Asia Pacific Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2021-2034

Table 19: Asia Pacific Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2021-2034

Table 20: Asia Pacific Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034

Table 21: Latin America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2021-2034

Table 22: Latin America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2021-2034

Table 23: Latin America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2021-2034

Table 24: Latin America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2021-2034

Table 25: Latin America Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034

Table 26: Middle East & Africa Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Drug Type, 2021-2034

Table 27: Middle East & Africa Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Indication, 2021-2034

Table 28: Middle East & Africa Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Route of Administration, 2021-2034

Table 29: Middle East & Africa Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, by Distribution Channel, 2021-2034

Table 30: Middle East & Africa Anti-Fungal Drugs Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 145

Buy Now

Download Free Sample

Security Code

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

(APAC) +91 744 740 1245
sales@fortunebusinessinsights.com